BWL Limited reports H1FY25 loss as operations remain suspended
BWL Limited reported a net loss of ₹18.63 lakh for H1FY25, a sharp reversal from the ₹246.24 lakh profit in FY25, as manufacturing operations stay suspended. Revenue fell to ₹10.51 lakh, while auditors issued an unmodified opinion on the unaudited results.

*this image is generated using AI for illustrative purposes only.
BWL Limited reported a net loss of ₹18.63 lakh for the half-year ended September 30, 2025, as manufacturing operations remain suspended due to working capital constraints. The company, which recorded a profit of ₹246.24 lakh in the fiscal year ended March 31, 2025, saw its total revenue decline to ₹10.51 lakh in the current period from ₹338.71 lakh in the previous year. The statutory auditor, M/s G Basu & Co., issued an unmodified opinion on the unaudited financial results, which were approved by the Board on November 13, 2025.
Financial Performance
The company's financial results for the half-year ended September 30, 2025, reflect the impact of the operational suspension. Total revenue stood at ₹10.51 lakh, down significantly from ₹338.71 lakh in the year ended March 31, 2025. Expenses for the half-year totaled ₹29.14 lakh, leading to a loss before tax of ₹18.63 lakh. In the corresponding period of the previous year, the company had reported a profit before tax of ₹246.24 lakh.
Key Financial Metrics (Half-Year Ended September 30, 2025)
| Metric | Amount (₹ in lacs) |
|---|---|
| Total Revenue | 10.51 |
| Total Expenses | 29.14 |
| Profit/(Loss) Before Tax | (18.63) |
| Net Profit/(Loss) for the Period | (18.63) |
| Basic Earnings Per Share (EPS) | (0.18) |
Operational Status and Auditor's Review
The notes to the financial results state that manufacturing operations are still under suspension due to working capital constraints. Management is exploring possibilities to restart the unit with a new product line. The unaudited balance sheet and cash flow statement were prepared on an estimated basis due to unforeseen circumstances and are expected to be regularized by the end of the fiscal year.
M/s G Basu & Co., Chartered Accountants, conducted the limited review in accordance with the Standard on Review Engagements (SRE) 2410. The review report, dated November 13, 2025, highlighted that the impact of footnote no. 5 regarding the estimated basis of financial statements is not readily quantifiable. The assets and liabilities as of September 30, 2025, totaled ₹476.40 lakh, compared to ₹382.99 lakh as of March 31, 2025.
What is the specific timeline and funding strategy management plans to utilize to restart manufacturing operations?
What are the details of the potential new product line, and is there sufficient market demand to justify the capital investment?
How will the company address the working capital constraints to prevent a recurrence of operational suspension post-restart?




























